Advertisement

Valve replacement in renal dialysis patients: bioprostheses versus mechanical prostheses

  • W. R. Eric Jamieson
  • V. Chan

Abstract

The incidence of end-stage chronic renal failure is increasing. In 1999, Schaubel and colleagues [1] reported on prevalence projections to 2005 in Canada, which can be considered representative of western countries. In 1981, the rate was 49.5 per million population, 2000 projected at 154 per million, and, in 2005, projected at 214.5 per million with a significant increase in nondiabetics 65 years and diabetics both in age categories 45–64 years and ≥65 years [1].

Keywords

Valve Replacement Valvular Heart Disease Mechanical Prosthesis Valve Replacement Surgery Prosthesis Type 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Schaubel DE, Morrison HI, Desmeules M, Parsons DA, Fenton SSA (1999) End-stage renal disease in Canada: prevalence projections to 2005. Can Med Assoc J 160:1557–1563Google Scholar
  2. 2.
    Bonow RO, Carabello B, deLeon AC Jr et al (1998) Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 98:1949–1984PubMedGoogle Scholar
  3. 3.
    Lucke JC, Samy RN, Atkins BZ et al (1997) Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thorac Surg 64:129–133CrossRefPubMedGoogle Scholar
  4. 4.
    Brinkman WT, Williams WH, Guyton RA et al (2002) Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection. Ann Thorac Surg 74:37–42CrossRefPubMedGoogle Scholar
  5. 5.
    Herzog CA, Ma JZ, Collins AJ (2002) Long-term survival of dialysis patients in the United States with prosthetic heart valves: should the ACC/AHA practice guidelines on valve selection be modified? Circulation 105:1336–1341CrossRefPubMedGoogle Scholar
  6. 6.
    Gultekin B, Ozkan S, Uguz E et al (2005) Valve replacement surgery in patients with end-stage renal disease: long-term results. Artificial Organs 29(12):972–975CrossRefPubMedGoogle Scholar
  7. 7.
    Horst M, Mehlhorn U, Hoerstrup SP, Suedkamp M, de Vivie R (2000) Cardiac surgery in patients with end-stage renal disease: 10-year experience. Ann Thorac Surg 69:96–101CrossRefPubMedGoogle Scholar
  8. 8.
    Filsoufi F, Chikwe J, Castillo JG, Rahmanian PB, Vassalotti J, Adams DH (2008) Prosthesis type has minimal impact on survival after valve surgery in patients with moderate to end-stage renal failure. Nephrol Dial Transplant 23(11):3613–3621CrossRefPubMedGoogle Scholar
  9. 9.
    Jamieson WRE, Cartier PC, Burwash IG et al (2004) Canadian Cardiovascular Society. Surgical management of valvular heart disease. Can J Cardiol 20E:1–120Google Scholar
  10. 10.
    Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr et al (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Amer Col Card 48(3):e1–e148CrossRefGoogle Scholar
  11. 11.
    Chan V, Jamieson WRE, Fleisher AG et al (2006) Valve replacement surgery in end-stage renal failure: mechanical prostheses versus bioprostheses. Ann Thorac Surg 81:857–862CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • W. R. Eric Jamieson
    • 1
  • V. Chan
  1. 1.3500 Jim Pattison PavilionVancouver General HospitalVancouverCanada

Personalised recommendations